| 前收盘价格 | 2.66 |
| 收盘价格 | 2.69 |
| 成交量 | 81,892 |
| 平均成交量 (3个月) | 128,871 |
| 市值 | 129,437,776 |
| 市盈率 (P/E TTM) | 3.42 |
| 预期市盈率 (P/E Forward) | 6.61 |
| 价格/销量 (P/S) | 0.490 |
| 52周波幅 | |
| 利润日期 | 5 Nov 2025 |
| 营业毛利率 | 10.55% |
| 营业利益率 (TTM) | 19.78% |
| 稀释每股收益 (EPS TTM) | 0.580 |
| 季度收入增长率 (YOY) | 4.70% |
| 季度盈利增长率 (YOY) | -52.10% |
| 流动比率 (MRQ) | 1.42 |
| 营业现金流 (OCF TTM) | 44.34 M |
| 杠杆自由现金流 (LFCF TTM) | 54.17 M |
| 资产报酬率 (ROA TTM) | 16.29% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Care Facilities (US) | 混合的 | 混合的 |
| Medical Care Facilities (全球的) | 混合的 | 混合的 | |
| 股票 | Biote Corp. | 看跌 | 看跌 |
AIStockmoo 评分
-0.9
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.0 |
| 平均 | -0.88 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries. |
|
| 部门 | Healthcare |
| 行业 | Medical Care Facilities |
| 投资方式 | Small Value |
| 内部持股比例 | 13.02% |
| 机构持股比例 | 65.98% |
该时间范围内无数据。
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 05 Nov 2025 | 公告 | Biote Reports Third Quarter 2025 Financial Results |
| 22 Oct 2025 | 公告 | Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合